EUVIMEDEUVIMED entdecken
Crossref

USP32 stabilizes SEMA4C to promote malignant behavior of colon cancer cells

Shurong Huang, Zongda Cai, Yangqiang Wang, Wei Zheng, Shiyang Zhan, Mingjin Huang, Jinping Chen

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.156162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Shurong Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China. Hauptthemen laut MEDLINE: Colonic Neoplasms, Ubiquitin Thiolesterase, Semaphorins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Fujian Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a prevalent and deadly malignancy. SEMA4C has been found to promote CRC progression, although the regulatory mechanisms behind SEMA4C expression in CRC tissues remain elusive. In this study, we examined 40 ubiquitin-specific proteases (USPs) that may influence SEMA4C stability and identified USP32 as a potent stabilizer. Through bioinformatics analysis, we discovered that USP32 mRNA expression is elevated in CRC tissues. Suppressing USP32 led to decreased cell viability, cell cycle arrest, reduced migration and invasion capabilities, and lower levels of proteins associated with epithelial-to-mesenchymal transition (EMT). USP32 directly interacts with SEMA4C in CRC cells, and its knockdown heightened SEMA4C ubiquitination and accelerated its degradation. Moreover, USP32 enhances the protein stability of SEMA4C by regulating its K48 ubiquitination. Overexpressing SEMA4C strengthened the weakened malignant behaviors of USP32-deficient CRC cells. These results indicate that USP32 acts as an oncogene in CRC by stabilizing SEMA4C, highlighting a new mechanism in CRC pathogenesis and suggesting USP32 as a novel potential therapeutic target for CRC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsUbiquitin ThiolesteraseSemaphorinsHumansGene Expression Regulation, NeoplasticComputational BiologyEpithelial-Mesenchymal TransitionUbiquitinationProtein StabilityOncogenesCell Line, Tumor

Stichwörter der Autor:innen

Colorectal cancerSEMA4CUSP32Ubiquitination

Substanzen

USP10 protein, humanSema4c protein, humanUbiquitin ThiolesteraseSemaphorins

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China.
  • Department of Gastrointestinal Surgery, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China. Electronic address: cip105AAA@163.com.

Förderung

  • Fujian Medical University

Zitieren

APA

Huang, S., Cai, Z., Wang, Y., Zheng, W., Zhan, S., Huang, M., & Chen, J. (2025). USP32 stabilizes SEMA4C to promote malignant behavior of colon cancer cells. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156162

Vancouver

Huang S, Cai Z, Wang Y, Zheng W, Zhan S, Huang M, et al. USP32 stabilizes SEMA4C to promote malignant behavior of colon cancer cells. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.156162

BibTeX
@article{Huang2025,
  author = {Huang, Shurong and Cai, Zongda and Wang, Yangqiang and Zheng, Wei and Zhan, Shiyang and Huang, Mingjin and Chen, Jinping},
  title = {USP32 stabilizes SEMA4C to promote malignant behavior of colon cancer cells},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.156162}
}
Kostenlos starten →